Valuation: Gedeon Richter

Market Cap 2,371B 7.51B 6.49B 6.1B 5.55B 10.43B 720B 10.59B 71.59B 28.06B 360B 28.2B 27.59B 1,199B P/E 2026 *
9.11x
P/E 2027 * 8.26x
Enterprise Value 2,053B 6.5B 5.62B 5.28B 4.8B 9.03B 623B 9.17B 61.99B 24.29B 312B 24.42B 23.89B 1,038B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.9x
Free-Float
72.87%
Yield 2026 *
4.42%
Yield 2027 * 5.14%
1 week+2.39%
Current month+10.97%
1 month+9.48%
3 months+2.91%
6 months+17.71%
Current year+38.65%
1 week 34.98
Extreme 34.98
36.28
1 month 31.72
Extreme 31.72
36.28
3 years 21.84
Extreme 21.84
36.7
Manager TitleAgeSince
Chief Executive Officer 47 01/11/2017
Director of Finance/CFO - 01/05/2025
Chief Operating Officer - 01/01/2019
Director TitleAgeSince
Chairman 78 01/01/2017
Chairman 90 01/03/2024
Director/Board Member 65 26/04/2012
Change 5-day change 1-year change 3-year change Capi.($)
-2.55%+2.39%+35.92%+50.96% 7.57B
-0.37%-3.56%+14.24%+63.79% 47.23B
+0.21%-4.14%+52.60%+119.23% 39.62B
-0.03%-2.49%-8.50%+15.32% 12.09B
-1.41%-0.30%+12.82%+73.00% 11.8B
+0.58%0.00%+30.65%+148.80% 9.12B
-0.54%-0.84%+22.33%+40.09% 7.57B
+1.33%+0.89%+42.84%-12.50% 7.1B
-1.03%+2.39%+12.74%+195.78% 6.87B
-0.97%-3.50%-30.77%+22.72% 5.81B
Average -0.25%-0.63%+18.49%+71.72% 16.36B
Weighted average by Cap. -0.19%-2.14%+24.15%+78.94%

Financials

2026 *2027 *
Net sales 975B 3.09B 2.67B 2.51B 2.28B 4.29B 296B 4.35B 29.43B 11.53B 148B 11.59B 11.34B 493B 1,026B 3.25B 2.81B 2.64B 2.4B 4.51B 311B 4.58B 30.97B 12.14B 156B 12.2B 11.93B 519B
Net income 265B 840M 726M 683M 621M 1.17B 80.51B 1.18B 8.01B 3.14B 40.26B 3.15B 3.09B 134B 288B 913M 788M 742M 674M 1.27B 87.44B 1.29B 8.7B 3.41B 43.73B 3.43B 3.35B 146B
Net Debt -318B -1.01B -870M -819M -744M -1.4B -96.51B -1.42B -9.6B -3.76B -48.27B -3.78B -3.7B -161B -421B -1.33B -1.15B -1.08B -986M -1.85B -128B -1.88B -12.72B -4.99B -63.96B -5.01B -4.9B -213B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
-
Date Price Change
19/08/26 35.10 -2.55%
17/08/26 €36.02 +0.17%
14/08/26 €35.96 +1.35%
13/08/26 €35.48 -1.00%
12/08/26 €35.84 +1.19%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
13,000.00HUF
Average target price
12,928.86HUF
Spread / Average Target
-0.55%

Quarterly revenue - Rate of surprise